| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 3031 | 2011 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1361 | 2013 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 987 | 2019 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 637 | 2015 |
| Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Data analysis: Bahlo Melanie 2 Brown Matthew A 6 7 Browning Brian L 20 ... Nature genetics 41 (7), 824-828, 2009 | 545 | 2009 |
| Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination S Ramanathan, S Mohammad, E Tantsis, TK Nguyen, V Merheb, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 127-137, 2018 | 543 | 2018 |
| Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects NA Patsopoulos, LF Barcellos, RQ Hintzen, C Schaefer, CM Van Duijn, ... PLoS genetics 9 (11), e1003926, 2013 | 388 | 2013 |
| Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011 | 367 | 2011 |
| Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide JY Hor, N Asgari, I Nakashima, SA Broadley, MI Leite, N Kissani, A Jacob, ... Frontiers in neurology 11, 501, 2020 | 321 | 2020 |
| MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood MB Cox, MJ Cairns, KS Gandhi, AP Carroll, S Moscovis, GJ Stewart, ... PloS one 5 (8), e12132, 2010 | 305 | 2010 |
| Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings AJ Coles, JA Cohen, EJ Fox, G Giovannoni, HP Hartung, E Havrdova, ... Neurology 89 (11), 1117-1126, 2017 | 287 | 2017 |
| Autoimmune disease in first-degree relatives of patients with multiple sclerosis: a UK survey SA Broadley, J Deans, SJ Sawcer, D Clayton, DAS Compston Brain 123 (6), 1102-1111, 2000 | 270 | 2000 |
| Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy E Havrdova, DL Arnold, JA Cohen, HP Hartung, EJ Fox, G Giovannoni, ... Neurology 89 (11), 1107-1116, 2017 | 241 | 2017 |
| Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic W Brownlee, D Bourdette, S Broadley, J Killestein, O Ciccarelli Neurology 94 (22), 949-952, 2020 | 213 | 2020 |
| Worldwide incidence and prevalence of neuromyelitis optica: a systematic review V Papp, M Magyari, O Aktas, T Berger, SA Broadley, P Cabre, A Jacob, ... Neurology 96 (2), 59-77, 2021 | 206 | 2021 |
| The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. J Chataway, R Feakes, F Coraddu, J Gray, J Deans, M Fraser, ... Brain: a journal of neurology 121 (10), 1869-1887, 1998 | 206 | 1998 |
| Modelling genetic susceptibility to multiple sclerosis with family data C O’Gorman, R Lin, J Stankovich, SA Broadley Neuroepidemiology 40 (1), 1-12, 2012 | 205 | 2012 |
| Predictors of prolonged dysphagia following acute stroke S Broadley, D Croser, J Cottrell, M Creevy, E Teo, D Yiu, R Pathi, J Taylor, ... Journal of clinical neuroscience 10 (3), 300-305, 2003 | 199 | 2003 |
| SUNCT and SUNA: clinical features and medical treatment MH Williams, SA Broadley Journal of Clinical Neuroscience 15 (5), 526-534, 2008 | 165 | 2008 |
| The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis KS Gandhi, FC McKay, M Cox, C Riveros, N Armstrong, RN Heard, ... Human molecular genetics 19 (11), 2134-2143, 2010 | 155 | 2010 |
